https://www.mlo-online.com/disease/cancer/news/55397868/new-option-for-patients-with-treatment-resistant-advanced-melanoma-fdas-new-approvalMLO Onlineen2026-08-13T15:36:39.000ZNew option for patients with treatment-resistant advanced melanoma: FDA’s new approvalhttps://www.mlo-online.com/molecular/precision-medicine/news/55397865/thermo-fisher-scientific-and-michael-j-fox-foundation-collaborate-to-advance-proteomics-enabled-parkinsons-precision-medicineMLO Onlineen2026-08-13T15:27:54.000ZThermo Fisher Scientific and Michael J. Fox Foundation collaborate to advance proteomics-enabled Parkinson’s precision medicinehttps://www.mlo-online.com/molecular/news/55397855/advanced-cardiac-organoids-for-toxicity-testing-3d-ready-cardioid-supplement-kit-to-launch-in-fall-2026MLO Onlineen2026-08-13T15:13:49.000ZAdvanced cardiac organoids for toxicity testing: 3D Ready Cardioid Supplement Kit to launch in Fall 2026https://www.mlo-online.com/management/news/55397517/new-executive-order-announces-gold-standard-childhood-vaccine-recommendationsMLO Onlineen2026-08-12T15:03:53.000ZNew Executive Order announces Gold Standard Childhood Vaccine Recommendationshttps://www.mlo-online.com/diagnostics/pathology/news/55397489/leica-biosystems-receives-multiple-fda-clearances-for-digital-pathologyMLO Onlineen2026-08-12T14:07:27.000ZLeica Biosystems receives multiple FDA clearances for digital pathology